Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Arerugi = [Allergy]|November 15, 2019
[PREVALENCE OF FUNCTIONAL DYSPEPSIA SYMPTOMS IN PATIENTS WITH ASTHMA]Fuminori Tomyo, Naoya Sugimoto, Hikaru Toyota, et al.
The Journal of Allergy and Clinical Immunology. Global|March 17, 2025
Clinical remission of mild-to-moderate asthma: Rates, contributing factors, and stabilityMana Ishizuka, Naoya Sugimoto, Konomi Kobayashi, et al.
Breast Cancer (Tokyo, Japan)|November 18, 2024
Real-world incidence of and risk factors for abemaciclib-induced interstitial lung disease in Japan: a nested case-control study of abemaciclib-induced interstitial lung disease (NOSIDE)Sayuka Nakayama, Ayuha Yoshizawa, Junji Tsurutani, et al.
Allergology International : Official Journal of the Japanese Society of Allergology|December 4, 2024
Effectiveness of benralizumab in the Tokyo Asthma Study (TOAST): A real-world prospective interventional trialKatsunori Masaki, Maho Suzukawa, Hitoshi Sasano, et al.
The Journal of Allergy and Clinical Immunology|May 27, 2026
Differential responses of group 2 innate lymphoid cells and TH2 cells to benralizumab in severe asthmaMisato Irie, Hiroki Kabata, Takashi Kamatani, et al.
Allergy, Asthma & Immunology Research|June 1, 2026
Risk Factors for COVID-19 mRNA Vaccine-Associated Exacerbations in Patients With Obstructive Airway Diseases: REsearch for Asthma and COPD ExacerbaTION Caused by COVID-19 mRNA Vaccination (REACTION Study)Tatsuro Suzuki, Yoshihiro Kanemitsu, Naoya Sugimoto, et al.
The Journal of Allergy and Clinical Immunology|May 21, 2026
One-Year Clinical Remission with Tezepelumab in Severe Asthma: TERESA Single-Arm Prospective StudyKeiko Kan-O, Hiroko Watanabe, Kenji Chibana, et al.
Pageof 4